Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This research project will determine the specific combination of two naturally-occurring anti-infective agents that gives the strongest antibiotic effect against a multi-drug-resistant bacteria called methicillin-resistant Staphylococcus aureus, known as MRSA. As MRSA is a leading cause of skin infection, the anti-infective agents will be incorporated into a specialized wound care film, designed to heal wounds and prevent infection by MRSA and other bacterial pathogens. First, films will be tested in order to determine the best composition of non-medicinal ingredients which will allow formation of a wound-healing hydrogel, maintain film integrity, and sustained release of the anti-infective agents over a five day period. Finally, the optimal amount anti-infective agents to be used in the films will be determined by testing for elimination MRSA and other bacterial pathogens over a continuous five day period. The partner organization will benefit from the development of an anti-infective wound care system which it can further develop for use in medical care settings.
Charles Thompson;Thomas Chang
Andira Pharmaceuticals
Life Sciences
Professional, scientific and technical services
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.